Transforming Medicine Commercialisation
Enriching Lives
We are dedicated to pioneering innovations in medicine commercialisation to improve the lives of those living with rare diseases.
“There is a dearth of new medicines for rare diseases and when innovations do come along they take too long to get to patients. The only medicines that matter, are those available to patients, so we are committed to supporting patient access through our focus on commercial excellence.”
John Irwin, CCO
Our Mission
Our mission is to be the partner of choice for BioPharma SMEs in bringing their innovative medicines to European patients with life-threatening or chronically debilitating conditions.
The Oranda Leadership Team
Ahmed Al-Derzi
Chief Executive Officer & Co-Founder
Seasoned entrepreneur with over 25 years of industry leadership experience.
Builder of lean and agile companies from inception, driving organic growth, and fostering profitability.
Personal Mission - Instilling a clear vision and purpose aimed at delivering the business development ambitions of the organisation and ultimately serving patients with rare diseases better.
John Irwin
Chief Commercial Officer & Co-Founder
Market access pathfinder with an extensive track record of success in commercializing high-value orphan medicines across Europe and international markets.
Acknowledged subject matter expert in International Pricing and Reimbursement.
Personal Mission - building and realizing the inherent value that rare disease medicines bring to patients and their families.
Zlatko Sisic, MD
Chief Medical Officer
Industry veteran with over two decades of experience spanning both commercial and medical affairs leadership roles.
Recognised industry leader in developing robust product development and medical affairs strategies for rare disease medicines.
Personal Mission - To optimise patient experience and outcomes by understanding, communicating and addressing their unmet medical needs.